Phase II capecitabine and gemcitabine fixed dose rate (FDR) in patients with advanced pancreatic cancer

被引：0
|
作者：
Tonini, G.
Vincenzi, B.
Vasile, E.
Catalano, V.
Virzi, V.
Fontana, A.
Intagliata, S.
Catalano, G.
Falcone, A.
Santini, D.
机构：
[1] Univ Campus Bio Medico, Rome, Italy
[2] USL 6, Dept Oncol, Livorno, Italy
[3] San Salvatore Hosp, Pesaro, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15530
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase II capecitabine and gemcitabine fixed dose rate (FDR) in patients with advanced pancreatic cancer
    Santini, D.
    Vincenzi, B.
    Masi, G.
    Catalano, V
    Virzi, V.
    Vasile, E.
    Fontana, A.
    Intagliata, S.
    Catalano, G.
    Falcone, A.
    Tonini, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 59 - 60
  • [2] Phase II capecitabine and gemcitabine fixed dose rate (FDR) in patients with advanced pancreatic cancer
    Santini, D.
    Vincenzi, B.
    Masi, G.
    Catalano, V.
    Virzi, V.
    Fontana, A.
    Vasile, E.
    Intagliata, S.
    Catalano, G.
    Falcone, A.
    Tonini, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] PHASE II CAPECITABINE AND GEMCITABINE FIXED DOSE RATE (FDR) IN PATIENTS WITH ADVANCED PANCREATIC CANCER
    Santini, D.
    Vincenzi, B.
    Masi, G.
    Catalano, V
    Virzi, V.
    Vasile, E.
    Fontana, A.
    Intagliata, S.
    Catalano, G.
    Falcone, A.
    Tonini, G.
    ANNALS OF ONCOLOGY, 2009, 20 : 104 - 104
  • [4] Phase II study of induction chemotherapy with fixed dose rate (FDR) gemcitabine and cisplatin followed by concurrent chemoradiation with capecitabine for locally advanced pancreatic cancer (LAPC)
    Kim, J.
    Im, S.
    Park, H.
    Chie, E.
    Hwang, J.
    Kim, J.
    Kim, T.
    Bang, Y.
    Ha, S.
    Yoon, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Phase II trial of neoadjuvant fixed dose rate (FDR) gemcitabine with capecitabine (GX) combination chemotherapy in locally advanced pancreatic adenocarcinoma (LAPA)
    Lee, J.
    Lee, S.
    Kim, T.
    Lee, J.
    Park, D.
    Seo, D.
    Lee, S.
    Kim, M.
    Han, D.
    Kim, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Phase I study of fixed-dose rate (FDR) gemcitabine with capecitabine in advanced solid malignancies
    Attia, S.
    Eickhoff, J.
    Holen, K. D.
    Bailey, H.
    Alberti, D.
    Wilding, G.
    Liu, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Efficacy of alternating-week fixed dose rate gemcitabine (FDR gem) plus capecitabine (CAP) in advanced pancreatic cancer (APC).
    Johns, Claire
    Diaz, Celso L.
    Kerridge, William
    Hwang, Jimmy
    Ko, Andrew H.
    Ternpero, Margaret A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] A phase I trial of fixed-dose-rate (FDR) gemcitabine and irinotecan combination in patients with advanced pancreatic and biliary cancer.
    Sun, W
    Theobald, ME
    Hershock, D
    Haller, DG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 341S - 341S
  • [9] A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients
    Santini, Daniele
    Virzi, Vladimir
    Vasile, Enrico
    Vincenzi, Bruno
    Catalano, Vincenzo
    Graziano, Francesco
    Masi, Gianluca
    Bronte, Giuseppe
    Russo, Antonio
    Falcone, Alfredo
    Tonini, Giuseppe
    ONCOLOGY, 2012, 82 (02) : 75 - 82
  • [10] GEMCITABINE (G) FIXED RATE DOSE INFUSION (FDR) PLUS ERLOTINIB (E) IN PATIENTS WITH ADVANCED PANCREATIC CANCER (APC)
    Munoz, A.
    Azkona, E.
    Iza, E.
    Martinez, M.
    Lopez-Vivanco, G.
    Fernandez, R.
    Ruiz De Lobera, A.
    Rubio, I.
    Casas, R.
    Mane, J. M.
    ANNALS OF ONCOLOGY, 2010, 21 : 235 - 235
12345